References
- Williams GM, Kroes R, Munro IC. Safety evaluation and risk assessment of the herbicide Roundup and its active ingredient, glyphosate, for humans. Regul Toxicol Pharmacol 2000;31:117-65. https://doi.org/10.1006/rtph.1999.1371
- Talbot AR, Shiaw M-H, Huang J-S, Yang S-F, Goo T-S, Wang S-H, et al. Acute poisoning with a glyphosate-surfactant herbicide ('Roundup'): a review of 93 cases. Hum Exp Toxicol 1991;10:1-8. https://doi.org/10.1177/096032719101000101
- Richard S, Moslemi S, Sipahutar H, Benachour N, Seralini GE. Differential effects of glyphosate and roundup on human placental cells and aromatase. Environ Health Perspect 2005;113:716-20. https://doi.org/10.1289/ehp.7728
- Koller VJ, Furhacker M, Nersesyan A, Misik M, Eisenbauer M, Knasmueller S. Cytotoxic and DNA-damaging properties of glyphosate and Roundup in humanderived buccal epithelial cells. Arch Toxicol 2012;86:805-13. https://doi.org/10.1007/s00204-012-0804-8
- Lee SH, Kim SJ, Choi WI, Jin SC, Choi IJ, Lee JH. Genotoxicity of low-dose Glyphosate by Sister Chromatid Exchange. J Korean Soc Clin Toxicol 2014;12:8-13.
- De Roos AJ, Blair A, Rusiecki JA, Hoppin JA, Svec M, Dosemeci M, et al. Cancer incidence among glyphosateexposed pesticide applicators in the Agricultural Health Study. Environ Health Perspect 2005;113:49-54. https://doi.org/10.1289/ehp.7340
- Bolognesi C, Carrasquilla G, Volpi S, Solomon KR, Marshall EJ. Biomonitoring of genotoxic risk in agricultural workers from five colombian regions: association to occupational exposure to glyphosate. J Toxicol Environ Health A 2009;72:986-97. https://doi.org/10.1080/15287390902929741
- Schinasi L, Leon ME. Non-Hodgkin lymphoma and occupational exposure to agricultural pesticide chemical groups and active ingredients: a systematic review and metaanalysis. Int J Environ Res Public Health 2014;11:4449-527. https://doi.org/10.3390/ijerph110404449
- Reiter RJ. The melatonin rhythm: both a clock and a calendar. Experientia 1993;49:654-64. https://doi.org/10.1007/BF01923947
- Hardeland R, Pandi-Perumal SR, Cardinali DP. Melatonin. Int J Biochem Cell Biol 2006;38:313-6. https://doi.org/10.1016/j.biocel.2005.08.020
- Barlow-Walden LR, Reiter RJ, Abe M, Pablos M, Menendez-Pelaez A, Chen LD, et al. Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int 1995;26:497-502. https://doi.org/10.1016/0197-0186(94)00154-M
- Tan D, Reiter RJ, Manchester LC, Yan M, El-Sawi M, Sainz RM, et al. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2002;2:181-97. https://doi.org/10.2174/1568026023394443
- Cos S, Sanchez-Barcelo EJ. Melatonin and mammary pathological growth. Front Neuroendocrinol 2000;21:133-70. https://doi.org/10.1006/frne.1999.0194
- Anisimov VN, Zabezhinski MA, Popovich IG, Zaripova EA, Musatov SA, Andre V, et al. Inhibitory effect of melatonin on 7, 12-dimethylbenz[a]anthracene-induced carcinogenesis of the uterine cervix and vagina in mice and mutagenesis in vitro. Cancer Lett 2000;156:199-205. https://doi.org/10.1016/S0304-3835(00)00463-8
- Anisimov VN. Melatonin and colon carcinogenesis. In: Bartsch C, Bartsch H, Blask DE, Cardinali DP, Hrushesky WJM, Mecke D, editors. The Pineal Gland and Cancer. Heidelberg:Springer:2001. p.240-58.
- Cos S, Fern R, Mediavilla M. Melatonin and mammary cancer: a short review. Endocr Relat Cancer 2003;10:153-9.
- Subramanian P, Mirunalini S, Dakshayani KB, Pandi-Perumal SR, Trakht I, Cardinali DP. Prevention by melatonin of hepatocarcinogenesis in rats injected with Nnitrosodiethylamine. J Pineal Res 2007;43:305-12. https://doi.org/10.1111/j.1600-079X.2007.00478.x
- Mills E, Wu P, Seely D, Guyatt G. Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis. J Pineal Res 2005;39:360-6. https://doi.org/10.1111/j.1600-079X.2005.00258.x
- Vijayalaxmi, Reiter RJ, Herman TS, Meltz ML. Melatonin reduces gamma radiation-induced primary DNA damage in human blood lymphocytes. Mutat Res 1998;397:203-8. https://doi.org/10.1016/S0027-5107(97)00211-X
- Lee JH, Eom KS, Song DK, Suh SI, Kim DK. In vitro and in vivo effects of melatonin on sister chromatid exchange in human blood lymphocytes exposed to hypoxia. Drug Chem Toxicol 2015:1-4.
- Anisimov VN, Popovich IG, Zabezhinski MA, Anisimov SV, Vesnushkin GM, Vinogradova IA. Melatonin as antioxidant, geroprotector and anticarcinogen. Biochim Biophys Acta 2006;1757:573-89. https://doi.org/10.1016/j.bbabio.2006.03.012
- Sarto F, Faccioli MC, Cominato I, Levis AG. Aging and smoking increase the frequency of sister-chromatid exchanges (SCE) in man. Mutat Res 1985;144:183-7. https://doi.org/10.1016/0165-7992(85)90137-X
- Hirsch BA, Sentz KK, McGue M. Genetic and environmental influences on baseline SCE. Environ Mol Mutagen 1992;20:2-11. https://doi.org/10.1002/em.2850200103
- Wilson DM, 3rd, Thompson LH. Molecular mechanisms of sister-chromatid exchange. Mutat Res 2007;616:11-23. https://doi.org/10.1016/j.mrfmmm.2006.11.017
- Stults DM, Killen MW, Pierce AJ. The sister chromatid exchange (SCE) assay. Methods Mol Biol 2014;1105:439-55.
- Tucker JD, Auletta A, Cimino MC, Dearfield KL, Jacobson-Kram D, Tice RR, et al. Sister-chromatid exchange: second report of the Gene-Tox Program. Mutat Res 1993;297:101-80. https://doi.org/10.1016/0165-1110(93)90001-4
- Hagmar L, Bonassi S, Stromberg U, Brogger A, Knudsen LE, Norppa H, et al. Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res 1998;58:4117-21.
- Mourelatos D. Sister chromatid exchange assay as a predictor of tumor chemoresponse. Mutat Res Genet Toxicol Environ Mutagen 2016;803-804:1-12. https://doi.org/10.1016/j.mrgentox.2016.03.011
- Galley HF, Lowes DA, Allen L, Cameron G, Aucott LS, Webster NR. Melatonin as a potential therapy for sepsis: a phase I dose escalation study and an ex vivo whole blood model under conditions of sepsis. J Pineal Res 2014;56:427-38. https://doi.org/10.1111/jpi.12134
- Shokouhi G, Tubbs RS, Shoja MM, Hadidchi S, Ghorbanihaghjo A, Roshangar L, et al. Neuroprotective effects of high-dose vs low-dose melatonin after blunt sciatic nerve injury. Childs Nerv Syst 2008;24:111-7.